Position in JNJ
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$746,671
+$28,018 QoQ
Shares Held
2,940
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#3,288
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Ascent Wealth Partners, LLC holds $36,435,678 across 7 Drug Manufacturers - General names. JNJ ranks #7 (2.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
64,219 | $16,160,069 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
58,756 | $7,423,233 | |
| 3 | AMGN |
Amgen Inc
|
14,199 | $5,141,741 | |
| 4 | NVS |
Novartis AG
|
16,473 | $2,581,648 | |
| 5 | MRK |
Merck & Co., Inc.
|
17,254 | $2,217,139 | |
| 6 | PFE |
Pfizer Inc
|
89,916 | $2,165,177 | |
| 7 | JNJ |
Johnson & Johnson
This page
|
2,940 | $746,671 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $746,671 | 2,940 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $718,653 | 2,940 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $584,426 | 2,824 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $526,407 | 2,839 | Shares | Sole | 2025-10-21 | |
| 2025-06-30 | $440,683 | 2,885 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $499,344 | 3,011 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $426,773 | 2,951 | Shares | Sole | 2025-02-04 | |
| 2024-09-30 | $493,796 | 3,047 | Shares | Sole | 2024-10-31 | |
| 2024-06-30 | $470,342 | 3,218 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $540,218 | 3,415 | Shares | Sole | 2024-05-01 | |
| 2023-12-31 | $3,295,301 | 21,024 | Shares | Sole | 2024-01-22 | |
| 2023-09-30 | $3,401,424 | 21,839 | Shares | Sole | 2023-10-20 | |
| 2023-06-30 | $3,648,391 | 22,042 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $3,336,685 | 21,527 | Shares | Sole | 2023-04-25 | |
| 2022-12-31 | $334,221 | 1,892 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $310,874 | 1,903 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $255,081 | 1,437 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $384,589 | 2,170 | Shares | Sole | 2022-05-02 | |
| 2021-12-31 | $4,936,224 | 28,855 | Shares | Sole | 2022-01-27 | |
| 2021-09-30 | $4,554,946 | 28,204 | Shares | Sole | 2021-11-01 | |
| 2021-06-30 | $4,676,474 | 28,387 | Shares | Sole | 2021-07-30 | |
| 2021-03-31 | $4,727,692 | 28,766 | Shares | Sole | 2021-04-26 | |
| 2020-12-31 | $4,483,441 | 28,488 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $4,253,054 | 28,567 | Shares | Sole | 2020-10-22 | |
| 2020-06-30 | $3,989,251 | 28,367 | Shares | Sole | 2020-07-21 | |
| 2020-03-31 | $3,615,385 | 27,571 | Shares | Sole | 2020-04-29 | |
| No filing history on record for this holder in this stock. | ||||||